Overview of Dr. Hu
Dr. Rachel Hu is an oncologist in Murray, UT and is affiliated with multiple hospitals in the area, including Intermountain Medical Center, LDS Hospital, Riverton Hospital, and Alta View Hospital. She received her medical degree from University of Missouri-Columbia School of Medicine and has been in practice 2 years. She is one of 63 doctors at Intermountain Medical Center and one of 49 doctors at LDS Hospital who specialize in Oncology. She has 8 publications and over 50 citings.
Office
5171 S Cottonwood St
Suite 610
Murray, UT 84107
Education & Training
Cleveland Clinic FoundationChief Fellow, Hematology/Oncology, 2018 - 2020
Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 2017 - 2020
Duke University HospitalResidency, Internal Medicine, 2014 - 2017- Duke University HospitalInternship, Internal Medicine, 2014 - 2015
University of Missouri-Columbia School of MedicineClass of 2014- Purdue UniversityBS, Pharmaceutical Sciences, Summa Cum Laude, 2006 - 2010
Certifications & Licensure
UT State Medical License 2020 - 2026
ID State Medical License 2022 - 2025
NV State Medical License 2022 - 2025
WY State Medical License 2022 - 2025
OH State Medical License 2017 - 2021
NC State Medical License 2014 - 2017- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Alpha Omega Alpha Honor Medical Society
- Rho Chi Pharmacy Honor Society
- Clinical Instructor Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, 2020
Clinical Trials
- Rituximab and Acalabrutinib in Newly Diagnosed B Cell Post Transplant Lymphoproliferative Disorder Start of enrollment: 2020 Sep 02
- ME-401 and R-CHOP in Newly Diagnosed Diffuse Large B-Cell Lymphoma Start of enrollment: 2021 Apr 28
Publications & Presentations
PubMed
- 14 citationsMulticenter analysis of geriatric fitness and real-world outcomes in older patients with classical Hodgkin lymphomaVictor M. Orellana-Noia, Krista Isaac, Mary-Kate Malecek, Nancy L. Bartlett, Timothy J Voorhees
Blood Advances. 2021-09-28 - 25 citationsProstate-specific antigen response in black and white patients treated with abiraterone acetate for metastatic castrate-resistant prostate cancer.Sundhar Ramalingam, Michael S. Humeniuk, Rachel Hu, Julia Rasmussen, Patrick Healy
Urologic Oncology. 2017-01-23 - 12 citationsWhat is the role of sipuleucel-T in the treatment of patients with advanced prostate cancer? An update on the evidence.Rachel Hu, Daniel J. George, Tian Zhang
Therapeutic Advances in Urology. 2016-05-02
Abstracts/Posters
- Fitness and Anthracycline Use in Front-Line Therapy for Older Patients with Classical Hodgkin Lymphoma: A US Multi-Center Retrospective AnalysisRachel Hu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Treatment Outcomes with Purine Nucleoside Analog Alone or with Rituximab for Hairy Cell Leukemia Patients at First Relapse: A Multi-Center Outcomes Analysis61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Differences in Genomic Patterns between African Americans and Whites with Acute Myeloid Leukemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
